Interest of daratumumab in refractory AL amyloidosis in a 96-year-old patient

Vial, G; Lafargue, A; Mercie, P; Duffau, P; Ribeiro, E

Vial, G (通讯作者),Univ Hosp Ctr Bordeaux, Dept Internal Med & Clin Immunol, St Andre Hosp, 1 Rue Jean Burguet, F-33000 Bordeaux, France.

REVUE DE MEDECINE INTERNE, 2022; 43 (11): 673

Abstract

Systemic immunoglobulin light-chain (AL) amyloidosis is characterized by deposition of amyloid fibrils of light chains produced by clonal CD38 + plasm......

Full Text Link